 |
Corporate News
10-Nov-23
|
|
|
|
|
|
|
|
|
|
|
|
Biocon Biologics divests its non-crore branded formulations biz in India
|
|
|
|
|
|
|
|
Biocon Biologics, a subsidiary of Biocon has divested the businesses in relation to its non-core branded formulations in India, comprising, inter alia, of generic dermatology and nephrology small molecule formulations (BFI Non-Core Business) to Eris Lifesciences on a ‘slump sale' basis.
|
|
|
|
Previous News |
Biocon Ltd rises for third straight session
(
Hot Pursuit
-
16-Jan-26
13:05
)
|
|
|
Biocon concludes QIP issue of Rs 4,150 cr
(
Corporate News
-
15-Jan-26
12:10
)
|
|
|
Volumes soar at Polycab India Ltd counter
(
Hot Pursuit
-
14-Jan-26
11:00
)
|
|
|
Biocon to hold board meeting
(
Corporate News
-
14-Jan-26
10:04
)
|
|
|
Stock Alert: Biocon, Senco Gold, Jubilant Foodworks, Titan Company
(
Market Commentary
-
Stock Alert
07-Jan-26
07:58
)
|
|
|
Biocon Biologics to introduce three new biosimilar oncology assets
(
Corporate News
-
06-Jan-26
19:59
)
|
|
|
Biocon Ltd soars 0.1%, rises for fifth straight session
(
Hot Pursuit
-
23-Dec-25
13:00
)
|
|
|
Biocon arm secures global rights for Hulio from Fujifilm Kyowa Kirin Biologics Co
(
Hot Pursuit
-
23-Dec-25
11:23
)
|
|
|
Biocon Biologics secures full and exclusive global rights for Hulio® (biosimilar Adalimumab)
(
Corporate News
-
23-Dec-25
09:29
)
|
|
|
Stock Alert: Reliance Inds, Lupin, TCS, HCL Tech
(
Market Commentary
-
Stock Alert
19-Dec-25
08:08
)
|
|
|
Biocon launches its diabetes & obesity treatment drugs in Netherlands
(
Hot Pursuit
-
15-Dec-25
09:45
)
|
|
|
|
|
|
Other Stories |
|
|
|
|
|
|
|
|
|
|
|
|
|